Clinical Trial

A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis

Study acronym: D2570-204
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The target population is patients with active psoriatic arthritis. A total of 222 subjects are planned to be included.
Protocol Amendment History 1 change
notable Primary completion pushed: 2027-03-15 -> 2027-08-15 2026-04-23
Trial Details
NCT Number NCT07315061
Lead Sponsor InventisBio Co., Ltd
Conditions PsA (Psoriatic Arthritis)
Enrollment 222 participants
Start Date 2026-01-16
Primary Completion 2027-08-15 (estimated)
Study Completion 2028-08-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-22